Moes, H. R. http://orcid.org/0000-0002-0139-4107
Dafsari, H. S.
Jost, W. H.
Kovacs, N.
Pirtošek, Z.
Henriksen, T.
Falup-Pecurariu, C.
Minár, M.
Buskens, E.
van Laar, T.
Funding for this research was provided by:
Universitair Medisch Centrum Groningen (GR-AGIKO 18-02)
Article History
Received: 4 February 2024
Accepted: 3 May 2024
First Online: 15 July 2024
Declarations
:
: ‒ HRM received a PhD research grant from the University Medical Center Groningen, Junior Scientific Masterclass [grant number GR-AGIKO 18-02]. This PhD project includes the development and validation of the Dutch DAT Screening tool (D-DATS). HRM has received a speaker fee from Centrafarm.‒ HSD was funded by the EU Joint Program ‒ Neurodegenerative Disease Research (JPND), the Prof. Klaus Thiemann Foundation in the German Society of Neurology, the Felgenhauer Foundation, the Koeln Fortune program of the Medical Faculty of the University of Cologne and has received honoraria by Everpharma, Kyowa Kirin, Bial, Oruen, and Stadapharm.‒ WHJ has received speaker and consultant for AbbVie, Bial, Britannia/Stada, and Zambon.‒ NK has no disclosures.‒ ZP has received honoraria from AbbVie and Britannia.‒ TH has received honoraria for talks for AbbVie, Britannia, Convatec, Nordic Infucare, and NeuroDerm. She is PI at studies funded by AbbVie and Britannia. She is also a DMC member at a study sponsored by Lundbeck.‒ CFP has received royalties from Elsevier, Springer Verlag, honoraria from Abbvie, Zentiva, International Parkinson Disease and Movement Disorders Society, all outside of the present work.‒ MM has received honoraria from Abbvie, Stada, Medis, Ipsen, and Glenmark.‒ EB has no disclosures to report regarding this contribution.‒ TvL has received consulting fees from AbbVie, Britannia Pharm., Eurocept, and Clexio, and research grants from the Michael J. Fox Foundation, the Dutch Brain Foundation, and the University Medical Center Groningen.